Status:
COMPLETED
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
Lead Sponsor:
San Carlo Public Hospital, Potenza, Italy
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
18-43 years
Brief Summary
The purpose of this study is to prove that luteal phase supplementation with recombinant LH can solve the luteal phase deficiency after Gnrh agonist oocytes triggering in women at risk of OHSS
Detailed Description
The investigators enrolled patients, undergoing controlled ovarian stimulation for an IVF/ICSI cycles, who on the day of oocytes triggering were at risk of OHSS. These patients had an estradiol \> 40...
Eligibility Criteria
Inclusion
- patients with an oestradiol \> 4000 pg/ml on the oocytes triggering day
- patient with more than 24 follicles of diameter greater than 12 mm on the oocytes triggering day
Exclusion
- patients with no risk of OHSS on the oocytes triggering day
- patients with an oestradiol \< 4000 pg/ml on the oocytes triggering day
- patient with less than 24 follicles of diameter greater than 12 mm on the oocytes triggering day
Key Trial Info
Start Date :
June 30 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2014
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02200952
Start Date
June 30 2013
End Date
June 30 2014
Last Update
November 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San carlo Public Hospital
Potenza, Basilicate, Italy, 85100